Original Article Bivalirudin in TAVI patients for the reduction of thromboembolic events: Rationale and design of the BIVITAL trial Author(s): Mao C*, Jialing H, Zhengang Z, Yong P, Yanbiao L, Wenyu L and Yuan Feng
September 09-10, 2020
October 26-27, 2020
November 04-05, 2020
+44-7447-215064